BodeVet adds three clinical trial sites for StablePlate RXMay 3, 2018Maryland-based BodeVet, a developer of transfusion treatment options for the veterinary industry, has added three new locations for the clinical trial of StablePlate RX, a product used to treat acute uncontrolled hemorrhage in bleeding canine patients. Marketed as the world's first injectable, free-dried platelet-derived product, StablePlate RX is now being tested at Ethos Veterinary Health-owned Veterinary Specialty Hospital of San Diego and Wheat Ridge Animal Hospital in Denver, as well as the Randall B. Terry Jr. Companion Animal Veterinary Medical Center at North Carolina State University in Raleigh. "We now have 40 dogs enrolled in 11 clinical sites across the country to evaluate StablePlate RX Canine for control of life threatening hemorrhage in thrombocytopenic patients," said Anne Hale, DVM, CTO at BodeVet. BodeVet's existing trial sites include: Blue Pearl Specialty & Emergency Veterinary Hospital in Clearwater, Fla. Blue Pearl Specialty & Emergency Veterinary Hospital in Tampa, Fla. Blue Pearl Specialty & Emergency Veterinary Hospital in Queens, N.Y. Blue Pearl Specialty & Emergency Veterinary Hospital in Paramus, N.J. Blue Pearl Specialty & Emergency Veterinary Hospital in Spring, Texas Cornell University College of Veterinary Medicine Companion Animal Hospital in Ithaca, N.Y. University of Georgia College …
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
BodeVet, distributor partners prepare to launch StablePlate RXMarch 29, 2018BodeVet, a company that develops novel blood products for use in hemostasis and regenerative medicine for the veterinary industry, has partnered with Blue Ridge Veterinary Blood Bank, HemoSolutions, and Northwest Veterinary Blood Bank to support distribution of its first product, StablePlate RX. Billed as the world's first injectable freeze-dried platelet derived product, StablePlate RX Canine is used to treat acute uncontrolled hemorrhage in bleeding canine patients, according to Anne Hale, DVM, chief technical officer for the Rockville, Md., company. Last year, BluePearl Veterinary Partners, Friendship Animal Hospital, Cornell University, the University of Georgia, and Iowa State University participated in clinical trials; Ethos Veterinary Health and North Carolina State University recently joined the clinical trial group, as well. Findings are to be released later this year. For more information on BodeVet, StablePlate RX, or its team of experts in veterinary transfusion medicine, visit bodevet.com.
